Nomic and Wellcome Sanger Institute Collaborate to Bring Protein-Level Resolution to the Genetics of Immune Diversity Nomic Bio Inc. announced a research collaboration with the Wellcome Sanger Institute to perform large-scale proteomic profiling of human-derived peripheral blood mononuclear cell (PBMC)…
Pelago Bioscience acquires RG Discovery, forming an integrated drug discovery partner covering biology and chemistry Pelago Bioscience, a contract research organization (CRO) specializing in drug discovery and renowned for its cutting-edge cell target engagement assays, is pleased to announce the…
Deutsche Aircraft and Hexcel Announce Long‑Term Composite Partnership for the D328eco ® Regional Aircraft Program Deutsche Aircraft and Hexcel Corporation jointly announced the signing of a long‑term industrial partnership and supply agreement focused on advanced composite solutions for the D328eco, the next‑generation…
L&T Technology Services, Databricks Partner to Deliver Industrial AI at Scale for Asset-Intensive Industries L&T Technology Services a global leader in AI, Digital & ER&D Consulting Services, announced a strategic go-to-market partnership with Databricks, the leading Data and AI company, to…
Watchmaker to Unveil New Technologies Addressing NGS Workflow Bottlenecks and Sequencing Accuracy Challenges at ESHG 2026 Watchmaker Genomics, a leader in high-performance NGS workflow solutions, announced it will unveil two new technologies at the European Society of Human Genetics (ESHG)…
Seek Labs Maps 25/25 Viral Families through BioSeeker, Advancing a New Model for Sequence-Directed Antiviral Discovery Seek Labs, a private TechBio company building programmable platforms to decode, program, and resolve diseases, announced it has mapped CRISPR-addressable regions across 25 out…
Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline Gilead Sciences, Inc. and Lakefront Biotherapeutics NV announced the successful completion of the previously announced acquisition of Ouro Medicines to advance T cell engager therapies for autoimmune diseases.…
Onchilles Pharma Doses First Patient in Phase 1/2 Clinical Trial of N17350 for Advanced Solid Tumors Onchilles Pharma, a clinical-stage biotechnology company pioneering next-generation cytotoxic therapeutics that harness the ELANE pathway, today announced that the first patient has been dosed…
Nephrodite’s Holly™ Implantable Continuous Dialysis System Awarded Selection into FDA’s TAP to Accelerate Development and Patient Access Nephrodite, Inc., a medical device company developing an implantable, continuous renal replacement system, announced that its Holly™ system has been selected to participate in…
Hexcel, NIAR Break Ground on New Hexcel Applications Center at Wichita State University Hexcel Corporation a global leader in advanced composite materials, announced the groundbreaking of the Hexcel Applications Center at Wichita State University’s National Institute for Aviation Research (NIAR).…
Wolters Kluwer and Radiological Society of North America Establish 10-Year Agreement to Advance Global Access to Leading Radiology Research Journals Wolters Kluwer Health announced a new 10-year agreement to publish the Radiological Society of North America (RSNA) portfolio of five specialty journals…
Turn Therapeutics Announces Peer-Reviewed Publication in Journal of Dermatological Treatment Highlighting GX-03 Activity in IL-36 Associated Inflammatory Model Turn Therapeutics Inc. a clinical-stage biotechnology company focused on developing localized therapies for inflammatory and infectious skin diseases, announced the publication of…